is retatrutide glp 1 or glp 3 Eli Lilly just announced striking Phase results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% GLP-3 R_RUO BIOPEPMED
Pay in 4 interest-free payments of $7.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7

























